Increased susceptibility to hyperoxic lung injury and alveolar simplification in newborn rats by prenatal administration of benzo[a]pyrene

Toxicology Letters

Volumn 230, Issue 2, 2014, Pages 322-332

  Thakur, Vijay S ^a   Liang, Yanhong W ^a   Lingappan, Krithika ^a   Jiang, Weiwu ^a   Wang, Lihua ^a   Barrios, Roberto ^b   Zhou, Guodong ^c   Guntupalli, Bharath ^a   Shivanna, Binoy ^a   Maturu, Paramahamsa ^a   Welty, Stephen E ^a   Moorthy, Bhagavatula ^a   Couroucli, Xanthi I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Alveolar simplification; Cytochrome P4501A1 1A2 1B1; Hyperoxic lung injury; Maternal benzo a pyrene; Newborn rat; Oxidative stress

Indexed keywords

BENZO[A]PYRENE; CIGARETTE SMOKE; CORN OIL; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DNA ADDUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; HYPEROXIA; LUNG INJURY; MATERNAL SMOKING; NONHUMAN; OXIDATIVE STRESS; PRENATAL EXPOSURE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TISSUE PERFUSION; WESTERN BLOTTING; ANALYSIS; ANIMAL; COMPLICATION; DRUG EFFECTS; FEMALE; FETUS; FISCHER 344 RAT; GENETICS; LUNG ALVEOLUS; NEWBORN; PREGNANCY; TOXICITY;

ANIMALS; ANIMALS, NEWBORN; BENZO(A)PYRENE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1B1; DNA ADDUCTS; FEMALE; FETUS; HYPEROXIA; LUNG INJURY; PREGNANCY; PULMONARY ALVEOLI; RATS; RATS, INBRED F344;

EID: 84907167579     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.03.006     Document Type: Article

References (57)

1. Agency for Toxic Substances and Disease R Toxicological profile for polycyclic aromatic hydrocarbons (PAHs) 1995.
2. Ambalavanan N., Walsh M., Bobashev G., Das A., Levine B., Carlo W.A., Higgins R.D., Network N.N.R. Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants. Pediatrics 2011, 127:e106-e116.
3. Anderson L.M., Jones A.B., Miller M.S., Chauhan D.P. Metabolism of transplacental carcinogens. IARC Sci. Publ. 1989, 155-188.
4. Anderson L.M., Jones A.B., Riggs C.W. Long-term (imprinting) effects of transplacental treatment of mice with 3-methylcholanthrene or beta-naphthoflavone on hepatic metabolism of 3-methylcholanthrene. Pharmacol. Toxicol. 1991, 69:178-188.
5. Anderson L.M., Jones A.B., Riggs C.W., Kovatch R.M. Modification of transplacental tumorigenesis by 3-methylcholanthrene in mice by genotype at the Ah locus and pretreatment with beta-naphthoflavone. Cancer Res. 1989, 49:1676-1681.
6. Andres R.L., Day M.C. Perinatal complications associated with maternal tobacco use. Semin. Neonatol. 2000, 5:231-241.
7. Antonucci R., Contu P., Porcella A., Atzeni C., Chiappe S. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia?. J. Perinat. Med. 2004, 32:272-277.
8. Autrup H., Vestergaard A.B. Transplacental transfer of environmental genotoxins-polycyclic aromatic hydrocarbon-albumin in nonsmoking women. Environ. Health Perspect. 1996, 104(3):625-627.
9. Barker D.J., Gluckman P.D., Robinson J.S. Conference report: fetal origins of adult disease-report of the First International Study Group, Sydney, 29-30 October 1994. Placenta 1995, 16:317-320.
10. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Sem. Fetal Neonatal Med. 2010, 15:223-229.
11. Bhattacharya S., Mariani T.J. Systems biology approaches to identify developmental bases for lung diseases. Pediatr. Res. 2013, 73:514-522.
12. Burns K.A., Rodriguez K.F., Hewitt S.C., Janardhan K.S., Young S.L., Korach K.S. Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model. Endocrinology 2012, 153:3960-3971.
13. Coalson J.J., Winter V.T., Siler-Khodr T., Yoder B.A. Neonatal chronic lung disease in extremely immature baboons. Am. J. Respir. Crit. Care Med. 1999, 160:1333-1346.
14. Couroucli X.I., Liang Y.H., Jiang W., Wang L., Barrios R., Yang P., Moorthy B. Prenatal administration of the cytochrome P4501A inducer, beta-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants. Toxicol. Appl. Pharmacol. 2011, 256:83-94.
15. Couroucli X.I., Welty S.E., Geske R.S., Moorthy B. Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury. Mol. Pharmacol. 2002, 61:507-515.
16. Crapo J.D. Morphologic changes in pulmonary oxygen toxicity. Annu. Rev. Physiol. 1986, 48:721-731.
17. Delpisheh A., Brabin L., Brabin B.J. Pregnancy, smoking and birth outcomes. Women's Health 2006, 2:389-403.
18. Duarte-Salles T., Mendez M.A., Meltzer H.M., Alexander J., Haugen M. Dietary benzo(a)pyrene intake during pregnancy and birth weight: Associations modified by vitamin C intakes in the Norwegian Mother and Child Cohort Study (MoBa). Environ. Int. 2013, 60C:217-223.
19. Duarte-Salles T., Mendez M.A., Pessoa V., Guxens M., Aguilera I., Kogevinas M., Sunyer J. Smoking during pregnancy is associated with higher dietary intake of polycyclic aromatic hydrocarbons and poor diet quality. Public Health Nutr. 2010, 13:2034-2043.
20. Fessel J.P., Porter N.A., Moore K.P., Sheller J.R., Roberts L.J. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16713-16718.
21. Freeman B.A., Crapo J.D. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 1981, 256:10986-10992.
22. Goil S., Truog W.E., Barnes C., Norberg M., Rezaiekhaligh M., Thibeault D. Eight-epi-PGF2alpha: a possible marker of lipid peroxidation in term infants with severe pulmonary disease. J. Pediatr. 1998, 132:349-351.
23. Guengerich F.P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 1988, 48:2946-2954.
24. Hazinski T.A., Noisin E., Hamon I., DeMatteo A. Sheep lung cytochrome P4501A1 (CYP1A1): cDNA cloning and transcriptional regulation by oxygen tension. J. Clin. Invest. 1995, 96:2083-2089.
25. Herbstman J.B., Tang D., Zhu D., Qu L., Siodin A., Li Z., Camann D., Perera F.P. Prenatal exposure to polycylic aromatic hydrocarbons, benzo[a]pyrene-DNA adducts, and genomic DNA methlyation in cord blood. Environ. Health Perspect. 2012, 120:733-738.
26. Horta B.L., Victora C.G., Menezes A.M., Halpern R., Barros F.C. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr. Perinat. Epidemiol. 1997, 11:140-151.
27. Huuskonen P., Storvik M., Reinisalo M., Honkakoski P., Rysa J., Hakkola J., Pasanen M. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin. Pharmacol. Ther. 2008, 83:542-550.
28. Janssen L.J. Isoprostanes: generation, pharmacology, and roles in free-radical-mediated effects in the lung. Pulm. Pharmacol. Ther. 2000, 13:149-155.
29. Jedrychowski W.A., Perera F.P., Tang D., Rauh V., Majewska R., Mroz E., Flak E., Stigter L., Spengler J., Camann D., Jacek R. The relationship between prenatal exposure to airborne polycyclic aromatic hydrocarbons (PAHs) and PAH-DNA adducts in cord blood. J. Expos. Sci. Environ. Epidemiol. 2013, 23:371-377.
30. Jiang W., Welty S.E., Couroucli X.I., Barrios R., Kondraganti S.R., Muthiah K., Yu L., Avery S.E., Moorthy B. Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. J. Pharmacol. Exp. Ther. 2004, 310:512-519.
31. Jules G.E., Pratap S., Ramesh A., Hood D.B. In utero exposure to benzo(a)pyrene predisposes offspring to cardiovascular dysfunction in later-life. Toxicology 2012, 295:56-67.
32. Lu L.J., Disher R.M., Reddy M.V., Randerath K. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene. Cancer Res. 1986, 46:3046-3054.
33. Miller M.D., Marty M.A. Impact of environmental chemicals on lung development. Environ. Health Perspect. 2010, 118:1155-1164.
34. Miller M.S. Transplacental lung carcinogenesis: a pharmacogenetic mouse model for the modulatory role of cytochrome P450 1A1 on lung cancer initiation. Chem. Res. Toxicol. 1994, 7:471-481.
35. Moorthy B., Parker K.M., Smith C.V., Bend J.R., Welty S.E. Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. J. Pharmacol. Exp. Ther. 2000, 292:553-560.
36. Morrow J.D., Roberts L.J. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am. J. Respir. Crit. Care Med. 2002, 166:S25-S30.
37. Natarajan G., Pappas A., Shankaran S., Kendrick D.E., Das A., Higgins R.D., Laptook A.R., Bell E.F., Stoll B.J., Newman N., et al. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum. Dev. 2012, 88:509-515.
38. Nieuwenhuijsen M.J., Dadvand P., Grellier J., Martinez D., Vrijheid M. Environmental risk factors of pregnancy outcomes: a summary of recent meta-analyses of epidemiological studies. Environ. Health 2013, 12:6.
39. Phillips D.H. Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 1999, 443:139-147.
40. Reddy M.V., Randerath K. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 1986, 7:1543-1551.
41. Sanyal M.K., Mercan D., Belanger K., Santella R.M. DNA adducts in human placenta exposed to ambient environment and passive cigarette smoke during pregnancy. Birth Defects Res. A: Clin. Mol. Teratol. 2007, 79:289-294.
42. Saugstad O.D. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD?. Acta Paediatr. 1997, 86:1277-1282.
43. Singh S.P., Gundavarapu S., Smith K.R., Chand H.S., Saeed A.I., Mishra N.C., Hutt J., Barrett E.G., Husain M., Harrod K.S., et al. Gestational exposure of mice to secondhand cigarette smoke causes bronchopulmonary dysplasia blocked by the nicotinic receptor antagonist mecamylamine. Environ. Health Perspect. 2013, 121:957-964.
44. Sinha A., Muthiah K., Jiang W., Couroucli X., Barrios R., Moorthy B. Attenuation of hyperoxic lung injury by the CYP1A inducer beta-naphthoflavone. Toxicol. Sci. 2005, 87:204-212.
45. Slaughter J.L., Pakrashi T., Jones D.E., South A.P., Shah T.A. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J. Perinatol. 2011, 31:635-640.
46. Smerdova L., Neca J., Svobodova J., Topinka J., Schmuczerova J., Kozubik A., Machala M., Vondracek J. Inflammatory mediators accelerate metabolism of benzo[a]pyrene in rat alveolar type II cells: the role of enhanced cytochrome P450 1B1 expression. Toxicology 2013, 314:30-38.
47. Suzuki K., Yoshinaga J. Inhalation and dietary exposure to polycyclic aromatic hydrocarbons and urinary 1-hydroxypyrene in non-smoking university students. Int. Arch. Occup. Environ. Health 2007, 81:115-121.
48. Teune M.J., van Wassenaer A.G., van Buuren S., Mol B.W., Opmeer B.C., Dutch P.C.S.G. Perinatal risk-indicators for long-term respiratory morbidity among preterm or very low birth weight neonates. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012, 163:134-141.
49. Urso P., Wirsiy Y.G., Cohen M.D., Adkins B. Changes in biologic and/or immunologic parameters induced by intratracheal instillation of pregnant mice with benzo[a]pyrene are potentially confounded by anesthesia. Inhal. Toxicol. 2010, 22:571-579.
50. Vento M., Moro M., Escrig R., Arruza L., Villar G., Izquierdo I., Roberts L.J., Arduini A., Escobar J.J., Sastre J., Asensi M.A. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009, 124:e439-e449.
51. Warner B.B., Stuart L.A., Papes R.A., Wispe J.R. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am. J. Physiol. 1998, 275:L110-L117.
52. Xu M., Miller M.S. Determination of murine fetal Cyp1a1 and 1b1 expression by real-time fluorescence reverse transcription-polymerase chain reaction. Toxicol. Appl. Pharmacol. 2004, 201:295-302.
53. Xu M., Nelson G.B., Moore J.E., McCoy T.P., Dai J., Manderville R.A., Ross J.A., Miller M.S. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, Balb/c, and F1 mice following in utero exposure to 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 2005, 209:28-38.
54. Xue W., Warshawsky D. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol. Appl. Pharmacol. 2005, 206:73-93.
55. Zahler S., Becker B.F. Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2alpha-III and iPE2-III). Prostaglandins Other Lipid Mediat. 1999, 57:319-331.
56. Zaynagetdinov R., Sherrill T.P., Kendall P.L., Segal B.H., Weller K.P., Tighe R.M., Blackwell T.S. Identification of myeloid cell subsets in murine lungs using flow cytometry. Am. J. Respir. Cell Mol. Biol. 2013, 49:180-189.
57. Zhou G.D., Zhu H., Phillips T.D., Wang J., Wang S.Z., Wang F., Amendt B.A., Couroucli X.I., Donnelly K.C., Moorthy B. Effects of dietary fish oil on the depletion of carcinogenic PAH-DNA adduct levels in the liver of B6C3F1 mouse. PLoS ONE 2011, 6:e26589.